Radcliffe Capital Management’s SeaStar Medical ICU Stock Holding History

Radcliffe Capital Management’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000	Closed	-$2.57M	–	891
2022 Q3	$2.57M	Hold	1,000	–	–	0.06%	528
2022 Q2	$2.54M	Hold	1,000	–	–	0.06%	550
2022 Q1	$2.53M	Hold	1,000	–	–	0.06%	527
2021 Q4	$2.51M	Hold	1,000	–	–	0.07%	448
2021 Q3	$2.51M	Hold	1,000	–	–	0.07%	384
2021 Q2	$2.48M	Hold	1,000	–	–	0.08%	404
2021 Q1	$2.45M	Buy	+1,000	New	+$2.45M	0.1%	364

Other funds holding ICU

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

CCFM

Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return

SWA

SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Radcliffe Capital Management's ICU Position: Q4 2022 in Review

Radcliffe Capital Management sold out of SeaStar Medical (ICU) in Q4 2022, closing a stake of 1,000 shares — an estimated $2.57M sold.

Radcliffe Capital Management first reported a position in ICU in Q1 2021 and held it in 7 quarters. The position peaked at $2.57M in Q3 2022. 8 funds tracked by Wall St. Rank hold ICU as of Q4 2022.

Radcliffe Capital Management reported no remaining SeaStar Medical position as of Q4 2022 after selling out during the quarter.
Radcliffe Capital Management sold 1,000 SeaStar Medical shares in Q4 2022, an estimated $2.57M.
Radcliffe Capital Management first reported a position in SeaStar Medical in Q1 2021 and held it in 7 quarters.
Radcliffe Capital Management's SeaStar Medical position peaked at $2.57M in Q3 2022.
8 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.